Literature DB >> 17524101

Transfusion premedications: a growing practice not based on evidence.

Aaron A R Tobian1, Karen E King, Paul M Ness.   

Abstract

Mesh：

Year:  2007        PMID： 17524101     DOI： 10.1111/j.1537-2995.2007.01242.x

Source DB:  PubMed          Journal:  Transfusion        ISSN： 0041-1132            Impact factor:   3.157


× No keyword cloud information.
  15 in total

1.  Transfusion-related adverse events in the Platelet Dose study.

Authors:  Richard M Kaufman; Susan F Assmann; Darrell J Triulzi; Ronald G Strauss; Paul Ness; Suzanne Granger; Sherrill J Slichter
Journal:  Transfusion       Date:  2014-07-28       Impact factor: 3.157

2.  Allergic agonists in apheresis platelet products are associated with allergic transfusion reactions.

Authors:  William J Savage; Jessica H Savage; Aaron A R Tobian; Chris Thoburn; Robert G Hamilton; John T Schroeder; Paul M Ness
Journal:  Transfusion       Date:  2011-08-29       Impact factor: 3.157

Review 3.  Scratching the surface of allergic transfusion reactions.

Authors:  William J Savage; Aaron A R Tobian; Jessica H Savage; Robert A Wood; John T Schroeder; Paul M Ness
Journal:  Transfusion       Date:  2012-09-24       Impact factor: 3.157

4.  Atopic predisposition of recipients in allergic transfusion reactions to apheresis platelets.

Authors:  William J Savage; Aaron A R Tobian; Jessica H Savage; Robert G Hamilton; Paul M Ness
Journal:  Transfusion       Date:  2011-05-13       Impact factor: 3.157

5.  The impact of platelet additive solution apheresis platelets on allergic transfusion reactions and corrected count increment (CME).

Authors:  Aaron A R Tobian; Alice K Fuller; Kristin Uglik; Daniel J Tisch; Prabhakar D Borge; Richard J Benjamin; Paul M Ness; Karen E King
Journal:  Transfusion       Date:  2013-11-19       Impact factor: 3.157

6.  The impact of apheresis platelet manipulation on corrected count increment.

Authors:  Matthew Karafin; Alice K Fuller; William J Savage; Karen E King; Paul M Ness; Aaron A R Tobian
Journal:  Transfusion       Date:  2012-01-10       Impact factor: 3.157

7.  Allergic transfusion reactions to platelets are associated more with recipient and donor factors than with product attributes.

Authors:  William J Savage; Aaron A Tobian; Alice K Fuller; Robert A Wood; Karen E King; Paul M Ness
Journal:  Transfusion       Date:  2011-01-07       Impact factor: 3.157

8.  Desensitization in allergic transfusion reactions: evidence from the Trial to Reduce Alloimmunization to Platelets.

Authors:  William Savage; Aaron A R Tobian; Paul M Ness; Richard M Kaufman
Journal:  Transfusion       Date:  2014-02       Impact factor: 3.157

9.  The cost-effectiveness of platelet additive solution to prevent allergic transfusion reactions.

Authors:  Seema Kacker; Paul M Ness; William J Savage; Kevin D Frick; Jeffrey McCullough; Karen E King; Aaron A R Tobian
Journal:  Transfusion       Date:  2013-01-30       Impact factor: 3.157

10.  Transfusion and component characteristics are not associated with allergic transfusion reactions to apheresis platelets.

Authors:  William J Savage; Aaron A R Tobian; Jessica H Savage; Robert G Hamilton; P Dayand Borge; Richard M Kaufman; Paul M Ness
Journal:  Transfusion       Date:  2014-09-10       Impact factor: 3.157
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.